Clinical Trial Update: Oxaliplatin in Cancer Patients With Impaired Kidney Function [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating oxaliplatin in cancer patients with impaired kidney function has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Chronic Kidney Disease

Drugs mentioned

• Eloxatin (oxaliplatin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Kidney Disease, Neoplasm | Phase 1 | Status: COMPLETED